FDA revise Quality guidance for Ophthalm
FDA has published a revised guidance on quality considerations for topical ophthalmic drug products –
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
